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Disease outbreaks caused by Vibrio parahaemolyticus 
in Puerto Montt, Chile, began in 2004 and reached a peak 
in 2005 at 3,600 clinical cases. Until 2006, every analyzed 
case was caused by the serovar O3:K6 pandemic strain. In 
the summer of 2007, only 475 cases were reported; 73% 
corresponded to the pandemic strain. This decrease was 
associated with a change in serotype of many pandemic 
isolates to O3:K59 and the emergence of new clinical 
strains. One of these strains, associated with 11% of the 
cases, was genotypically different from the pandemic strain 
but contained genes that were identical to those found on 
its pathogenicity island. These ﬁ  ndings suggest that patho-
genicity-related genes were laterally transferred from the 
pandemic strain to one of the different V. parahaemolyticus 
groups comprising the diverse and shifting bacterial popula-
tion in shellﬁ  sh in this region.
I
n 1998 in Antofagasta, Chile (23°39′S, 70°24′W), ≈300 
human cases of infection with Vibrio parahaemolyticus 
caused by consumption of contaminated seafood were re-
ported (1). Outbreaks have not been observed in this region 
since 1998. During 2004–2007, ≈7,000 cases were reported 
farther south in Puerto Montt (41°29′S, 72°24′W) (2–5). 
However, outbreaks generally have been decreasing; there 
were ≈1,500 cases in 2004, 3,600 in 2005, 900 in 2006, and 
475 in 2007 (6) (http://epi.minsal.cl/epi/html/Actualidad/
Vibrio.htm).
Until 2006, ≈100% of the cases analyzed were caused 
by a clonal group originally observed in Southeast Asia in 
1996 (4,5,7). This group was known as the V. parahaemo-
lyticus pandemic strain because it had reached coastal en-
vironments worldwide and caused outbreaks. It belongs to 
the O3:K6 serovar, although at least 21 serovariants have 
emerged since 1996 (8). These serovariants also have spe-
ciﬁ  c sequences corresponding to genes such as toxRS/new 
(9), open reading frame 8 (orf8) (10), and tdh, but lack oth-
ers such as trh, which is found in other pathogenic strains.
Genome sequencing of the RIMD2210633 pandemic 
strain showed that it has 2 sets of gene clusters that en-
code the type III secretion system (TTSS) apparatus (11). 
This apparatus is used by several gram-negative pathogenic 
bacteria to secrete and translocate virulence factor proteins 
into the cytosol of eukaryotic cells (12). TTSS1 is involved 
in cytotoxicity against HeLa cells, and TTSS2 is involved 
in enterotoxic activity in a rabbit ileal loop test (13). The 
ﬁ  rst cluster is located on the large chromosome, and the 
second is located on the small chromosome. The second 
cluster contains 2 copies of the tdh gene and is located on 
a pathogenicity island (a discrete genetic unit that contains 
genes responsible for pathogenicity and virulence) prob-
ably obtained by recent lateral transfer (11). TTSS2 has 
been found only in strains showing β-type hemolysis on 
a specialized blood agar medium known as Wagatsuma 
agar (11). This hemolysis is called the Kanagawa phenom-
enon and is considered a useful marker for identiﬁ  cation 
of pathogenic strains. Recently, TTSS genes related to the 
TTSS2 cluster were reported in clinical and environmental 
non-O1, non-O139 V. cholerae strains (14).
The clonal nature of the pandemic V. parahaemolyti-
cus isolates was ascertained by the similarity of patterns 
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obtained by genome restriction fragment length polymor-
phism–pulsed-ﬁ   eld gel electrophoresis (15), arbitrarily 
primed PCR (7,9), direct genome restriction enzyme analy-
sis (DGREA) (4), and multilocus sequence typing (MLST) 
(16,17). However, the pandemic strain is a minor fraction 
of a diverse and shifting V. parahaemolyticus population 
found in shellﬁ  sh in Puerto Montt (2). In an effort to under-
stand the epidemiology of these outbreaks, we studied V. 
parahaemolyticus isolates obtained from human cases and 
shellﬁ  sh during the summer of 2007. Our results indicate 
replacement of the O3:K6 pandemic strain by new serotype 
O3:K59 and new pathogenic V. parahaemolyticus groups. 
The decrease in the number of clinical cases may have been 
caused by diminution of the V. parahaemolyticus O3:K6 
pandemic group in regional seafood.
Methods
Strains
V.  parahaemolyticus RIMD 2210633 (VpKX) and 
RIMD 2210086 (VpI) were obtained from the Research 
Institute for Microbial Diseases, Osaka University, Osaka, 
Japan. The Chilean environmental strains, identiﬁ  ed  as 
PMA with a number according to origin and year of isola-
tion, were obtained from shellﬁ  sh samples obtained dur-
ing outbreaks from 2004 though 2007. Most strains have 
been described (4). PMC38.7, PMC60.7, PMC53.7, and 
PMC75.7 are isolates from clinical samples obtained in 
2007. Each of these isolates corresponds to the isolate type 
of the 23 groups differentiated by DGREA as described (4) 
and reported in this article.
Analysis
Samples of clinical cases and shellﬁ  sh were obtained 
and analyzed as described (4). Isolation, growth, and char-
acterization of isolates, including their DGREA patterns, 
were conducted as described (4,5). Each DGREA pattern 
found in 2007 was compared with those for previous years. 
When similarities in patterns were observed, their identity 
was checked by comparing patterns obtained in the same 
electrophoretic analysis.
PCR assays were performed by using ≈10 ng of to-
tal bacterial DNA per reaction tube. Ampliﬁ  cation condi-
tions were those previously reported for tlh, tdh, and trh 
(18), orf8 (19), and toxRS/new ( 9) genes. T3SS2 genes 
(VPA1335, VPA1338, VPA1339, VPA1341, VPA1342, 
VPA1346, VPA1349, VPA1354, VPA1355, VPA1362, 
and VPA1367) were ampliﬁ  ed by using primers reported 
for a microarray assay at 61ºC by Meador et al. (20). Genes 
VPA1321 and VPA1376, which are located at the extremes 
of the pathogenicity island, were ampliﬁ  ed by using primers 
designed using the Primer3 program (http://primer3.source-
forge.net). Sequences of these primers were VPA1321f: 5′-
TGACATGCACGGCAATAGAT-3′, VPA1321r: 5-ACAG
AGTTGGTTTCGCAGGT-3′, VPA1376 f: 5′-CATCGAG
CGATCTTTCACAA-3′, and VPA1376r: 5′-ACCGG
TTTCCAACCTTCTCT-3′. Housekeeping genes for MLST 
were ampliﬁ   ed by using primers for V.  parahaemolyti-
cus (17) and from the MLST website (http://pubmlst.org/
vparahaemolyticus) developed by Keith Jolley (University 
of Oxford, Oxford, UK) (21).
PCR products were puriﬁ  ed by using either the Wiz-
ard SV Gel or PCR Clean-Up Systems (Promega, Madison, 
WI, USA) and sequenced in both directions by Macrogen 
(Seoul, South Korea) or by McLAB (South San Francis-
co, CA, USA) by using forward and reverse ampliﬁ  cation 
primers or primers M13F and M13R (MLST loci). DNA 
sequences were analyzed individually and manually assem-
bled. Alignments and sequence similarities were obtained 
by using BioEdit software (22). Sequences obtained were 
deposited in GenBank under accession nos. EU185060–
EU185092.
Ampliﬁ  cation and sequencing of the variable region 
of the 16S rRNA (rrs) between nucleotides 357 and 518 
(Escherichia coli numbering) were performed as described 
(23). This analysis consisted of separation of rrs alleles in 
PMC38.7 by pulsed-ﬁ  eld gel electrophoresis and PCR am-
pliﬁ  cation of the variable region in excised bands as de-
scribed (24).
Results
V. parahaemolyticus Associated with 
Human Cases in 2007
V.  parahaemolyticus isolates from 37 human case-
patients with diarrhea from the summer of 2007 in the 
Puerto Montt region were analyzed and grouped according 
to serotype, presence of genetic markers (orf8, toxRS/new, 
tlh, tdh, trh), and distinctiveness of their DGREA patterns 
(Table 1; Figure 1). One isolate from each patient was char-
acterized. On the basis of genetic markers and DGREA pat-
tern, isolates from 27 patients corresponded to the pandem-
ic clonal group. However, 40% of the 20 serotyped strains 
of this group contained a K59 capsular antigen instead of 
the characteristic K6 antigen, and 25% cross-reacted with 
antisera for K6 and K59 antigens. Another difference from 
strains of previous years was that the relative number of 
cases associated with the pandemic strain (73%) was lower 
than the 100% observed in previous summers (4). Isolates 
from the other 27% of patients with clinical cases lacked 
the characteristic markers of the pandemic strains, i.e., 
orf8 and toxRS/new, and had 4 new DGREA groups. One 
of these groups contained 4 tdh-positive isolates (11% of 
cases). A second group contained 4 isolates positive for tdh 
and trh genes. The other 2 groups contained 1 isolate each, 
and both were negative for these 2 markers (Table 1). One 
164  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 2, February 2009Vibrio parahaemolyticus, Chile
isolate chosen as the type strain of each group was typed 
by MLST (17). MLST sequence type corresponded with 
groups determined by other analyzed genetic properties 
(Table 1).
Characterization of Nonpandemic Strains
Strains positive for tdh, other than the pandemic strain, 
had not been isolated from patients with clinical cases in 
Puerto Montt during the 3 previous summer outbreaks. It 
has been reported that this gene may be spread by insertion 
sequence–like elements (25,26). The possibility that tdh 
found in nonpandemic strains was derived from the pan-
demic strain was explored. PCR amplicons of the tdh gene 
of the 2 nonpandemic groups was sequenced in isolates 
designated as type strains for each group: PMC60.7 for the 
group containing tdh and trh and PMC38.7 for the group 
containing only tdh. The amplicon of isolate PMC60.7 had 
an identical sequence to that reported for tdhA except for 
1 nucleotide (11). Conversely, PMC38.7 had an identical 
sequence to that expected for a mixture of the 2 tdh genes 
in VpKX. These 2 genes differ slightly and the mixture of 
their PCR products should show polymorphisms in speciﬁ  c 
sites (11).
This observation suggested the presence of tdhS and 
tdhA genes in PMC38.7 with identical sequences to those 
found in the pandemic strain. Because these 2 genes are 
located close to each end of the pathogenicity island in 
chromosome 2 of the pandemic V. parahaemolyticus (11), 
the presence of the entire island was explored by PCR am-
pliﬁ  cation of 11 genes of TTSS2 located in the island and 
of genes VPA1321 and VPA1376 located at the extremes 
of the island near tdhA and tdhS, respectively. Each tested 
gene was found in the PMC38.7 strain, and sequences of 
their PCR products were identical to those reported for the 
pandemic strain genes, except for 1 nucleotide in VPA1342. 
Serotyping of PMC38.7 indicated an O10:K20 serovar. Be-
cause MC38.7 is genetically different from the pandemic 
strain (Table 1, Figure 1), the high degree of homology of 
these genes suggested that the entire pathogenicity island 
had recently been transferred from the pandemic strain.
PMC38.7 also differs from the pandemic strain and 
most clinical isolates by the presence of intragenomic het-
erogeneity among its multiple 16S rRNA genes, a feature 
seldom observed in clinical isolates but frequently observed 
among environmental isolates. This ﬁ   nding is probably 
caused by lateral transfer of rrs (23). Three rrs genes, with 
sequences corresponding to V. parahaemolyticus groups 
VpD1-B4, ATA65-B2, and VpKX-AB (23), were observed 
in PMC38.7.
V. parahaemolyticus Associated with Shellﬁ  sh
There are a large number of V.  parahaemolyticus 
strains in the environment in the Puerto Montt region. Only 
the pandemic strain was isolated from clinical samples 
before and during the summer of 2006, but 20 different 
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Table 1. Properties of Vibrio parahaemolyticus clinical isolates from Puerto Montt, Chile, summer 2007* 
Isolate tlh tdh trh orf8 ToxRS/new Serotype
DGREA
group MLST ST†
PMC50.7, 51.7, 41.7, 72.7, 1.7, 15.7, 16.7 + + – + + O3:K6 VpKX 3
PMC55.7, 56.7, 58.7, 28.7, 44.7, 73.7, 14.7, 18.7 + + – + + O3:K59 VpKX ND
PMC29.7, 42.7, 70.7, 11.7, 19.7 + + – + + O3:K6,59 VpKX ND
PMC59.7, 63.7, 64.7, 65.7, 66.7, 20.7, 22.7 ++–+ + N D V p K X N D
PMC38.7, 47.7, 57.7, 68.7 + + – – – O10:K20 38.7 63
PMC60.7, 25.7, 26.7, 27.7 + + + – – O1:KUT 60.7 64
PMC53.7 + – – – – O3:K59 1.5 28
PMC75.7 + – – – – O1:KUT 75.7 65
*Isolates with an undetermined serotype are in boldface. orf, open reading frame; DGREA, direct genome restriction enzyme analysis; MLST, multilocus 
sequence typing; ST, sequence type; ND, not determined. 
†Sequences are available from http://pubmlst.org/vparahaemolyticus. 
Figure. 1. Direct genome restriction enzyme analysis with NaeI of 
clinical isolates of Vibrio parahaemolyticus representative of the 
5 patterns observed during the outbreaks in Puerto Montt, Chile, 
January and February, 2007. Lanes MW, 100-bp size ladder; lane 
2, PMC38.7; lane 3, PMC60.7; lane 4, PMC53.7; lane 5, PMC75.7; 
lane 6, VpKX. (O3:K6 pandemic isolate). RESEARCH
strains were isolated from shellﬁ  sh during that period (2). 
Characterization of 52 isolates from 20 shellﬁ  sh samples 
during the summer of 2007 indicated ≥5 DGREA groups; 3 
of them were not previously observed (Table 2; Figure 2). 
This ﬁ  nding increases the number of different strains found 
in shellﬁ  sh of the region to 23. Figure 3 shows the num-
ber of shellﬁ  sh samples containing each of the 23 DGREA 
groups found during the past 4 years, including the sum-
mer of 2007 (2; this study). Only 4 of the 20 shellﬁ  sh sam-
ples examined produced tdh-positive enrichment cultures, 
which is indicative of pathogenic strains. However, no tdh-
positive isolates were obtained from these enrichments af-
ter plating on thiosulfate citrate bile salts sucrose agar.
T3SS2 Genes in Other Nonpandemic V. parahaemolyti-
cus Strains
Because the presence of TTSS2 genes is not exclusive 
to the pandemic strain (20), their occurrence in the other 
environmental and clinical V. parahaemolyticus DGREA 
groups found in Puerto Montt was explored. We analyzed 
by PCR ampliﬁ  cation 20 strains corresponding to 18 envi-
ronmental DGREA groups (PMA79, 112, 118, 189, 337, 
339, 3316, 1.5, 19.5, 22.5, 27.5, 13.6, 34.6, 36.6, 40.6, 1.7, 
11.7, and 21.7) and 1 strain from each of 3 new clinical 
groups (PMC60.7, 53.7, and 75.7) found in Puerto Montt in 
2007 for the VPA1335 gene (found in T3SS2). Among these 
strains, only PMA339, isolated from shellﬁ  sh in the sum-
mer of 2004, was positive. PCR ampliﬁ  cation of PMA339 
for the other genes in the pathogenicity island showed posi-
tive reactions for all the genes tested in PMC38.7. Never-
theless, sequences of amplicons showed strong differences 
from those found in PMC38.7 and those reported for the 
pandemic strain genome. Similarity ranged from 99.4% 
for VPA1362 to 93.8% for VPA1346; the average for all 
genes tested was 97.7%. These differences indicate a much 
larger evolutionary distance between the T3SS2 genes in 
PMA339 and the pandemic strain than between PMC38.7 
and the pandemic strain.
Discussion
The epidemiology of outbreaks caused by V. parahae-
molyticus in the Puerto Montt region is changing. The num-
ber of clinical cases caused by the pandemic strain has de-
creased, accompanied by a change of serotype from O3:K6 
to O3:K59. The changing serotype of the pandemic strain 
has been recently reviewed by Nair et al. (8). These authors 
showed that the more recent serotypes do not have the pro-
pensity for increasing hospital admissions observed with 
O3:K6, and some type of change in the epidemic process 
seems to be evident. Genes for the biosynthesis of capsular 
polysaccharides, which are major antigens (K) of V. para-
haemolyticus, are probably encoded in a gene cluster char-
acterized by variability that may occur through lateral gene 
transfer (27). Isolates reacting with antisera for K6 and K59 
antigens may have changed part of the K epitopes reacting 
with the commercial polyclonal antiserum.
The percentage of clinical cases caused by the pan-
demic strain decreased from 100% in 2006 to 73% in 2007. 
Four clinical strains, not previously observed, emerged in 
2007. Among these, 1 group representing 11% of the clini-
cal cases, with type strain PMC38.7, may have recently 
received the genes on the pathogenicity island of the pan-
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Table 2. Properties of Vibrio parahaemolyticus isolates from shellfish from Puerto Montt, Chile, summer 2007* 
Isolate tlh tdh trh orf8 ToxRS/new
DGREA
group MLST ST†
PMA4.7, 5.7, 6.7, 7.7, 8.7,15.7, 16.7, 17.7, 19.7, 20.7, 22.7, 
23.7, 24.7, 25.7, 26.7, 27.7, 28.7, 33.7, 37.7, 41.7, 42.7, 
43.7, 47.7, 48.7, 49.7
+ – – ND ND 34.6 ND
PMA9.7, 10.7, 12.7, 14.7, 18.7, 38.7 + – – ND ND 118 10
PMA1.7, 2.7, 3.7 + – – ND ND 1.7 ND
PMA11.7, 13.7 + – – ND ND 11.7 ND
PMA21.7 + – – ND ND 21.7 ND
*orf, open reading frame; DGREA, direct genome restriction enzyme analysis; MLST, multilocus sequence typing; ST, sequence type; ND, not determined.
†Sequences are available from http://pubmlst.org/vparahaemolyticus. 
Figure 2. Direct genome restriction enzyme analysis with NaeI of 
Vibrio parahaemolyticus isolates from shellﬁ  sh collected in Puerto 
Montt, Chile, summer 2007. Gel shows representative strains for 
every observed pattern. Patterns of groups observed in previous 
years are next to the type isolate of that group. Lanes MW, 100-bp 
size ladder; lane 2, PMA4.7; lane 3, 34.6; lane 4, PMA9.7; lane 5, 
118; lane 6, PMA1.7; lane 7, PMA11.7; lane 8, PMA21.7. Vibrio parahaemolyticus, Chile
demic strains. Pathogenicity island genes identical to those 
in the pandemic strain in this bacterial group and differ-
ences in housekeeping genes and DGREA patterns are best 
explained by transfer of the pathogenicity island from the 
pandemic strain to an indigenous strain. The indigenous V. 
parahaemolyticus population in shellﬁ  sh is diverse, and the 
predominant strains seem to change every year. A detailed 
examination of the putative genomic island in PMC38.7, its 
integration site, and its ﬂ  anking regions, will probably help 
differentiate among possible mechanisms of DNA transfer.
The presence of TTSS2 genes is not exclusive of the 
pandemic and PMC38.7 strain; they were also found in an 
environmental isolate of V. parahaemolyticus (PMA339). 
However, PMA339 has not been observed among clinical 
isolates. TTSS2 genes have been found in other V. para-
haemolyticus clinical strains (20); however, we identiﬁ  ed 
them in environmental strains. On the basis of sequences 
obtained from their amplicons, TTSS2 genes in PMA339 
seem to have independently evolved from the pandemic 
strain over a considerable time. Nevertheless, they are still 
more closely related to the TTSS2 of V. parahaemolyticus 
than to those recently found in non-O1 or non-O139 V. 
cholerae (14).
Little is known of the origin of the other 3 clini-
cal groups (60.7, 1.5, and 75.7). Group 60.7 contains tdh 
and trh, but this tdh does not seem to be derived from the 
pandemic strain. Strains of groups 1.5 and 75.7 lack both 
pathogenicity-associated genes, but ﬁ  nding these isolates in 
patients is not unusual (28). PMC75.7, a clinical strain, con-
tains a recA gene that is closely related to that of PMA339, 
the environmental isolate containing TTSS2 genes (17 and 
http://pubmlst.org/vparahaemolyticus). However, in view 
of a recent report (29), one should consider that the 2 hu-
man isolates lacking tdh or trh genes may correspond to 
nonvirulent strains that proliferate during infection with a 
virulent strain.
The abundance and frequency of pandemic and non-
pandemic V. parahaemolyticus in shellﬁ  sh seem to have 
been less in 2007 than in previous years. In 2006, 10 of 
20 shellﬁ  sh samples were positive for tdh after enrichment; 
in 2007, only 4 of 20 samples were positive. PCR ampli-
ﬁ  cation of colonies obtained after plating the enrichment 
culture on thiosulfate citrate bile salts sucrose agar enabled 
identiﬁ  cation of tdh-positive colonies in 6 samples in 2006; 
none could be identiﬁ  ed by the same method in 2007. The 
observed decrease in outbreaks was probably caused by a 
decrease in raw seafood consumption as a result of a public 
health campaign and a decrease in the load of the highly 
virulent pandemic strain in shellﬁ  sh. However, this tenden-
cy could change on the basis of dispersion and virulence of 
emerging pathogenic strains.
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